Clinical Trials Browser

Adenocarcinoma of the Prostate × Clear all

NCT01517451 2026-02-11

Radiation and Androgen Ablation for Prostate Cancer

Phase 1/2 Completed

45 enrolled 11 charts

Adenocarcinoma of the Prostate

NCT02203695 2025-10-28

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

Phase 2 Completed

86 enrolled 13 charts

Adenocarcinoma of the Prostate

NCT03686683 2024-10-08

ProVent

Phase 3 Completed

532 enrolled 14 charts

Adenocarcinoma of the Prostate

NCT04909294 2024-02-13

STEREO-RML

Phase NA Active not recruiting

Adenocarcinoma of the Prostate

NCT03535675 2023-05-22

Muscadine Plus (MPX) In Men With Prostate Cancer

Phase 3 Terminated

59 enrolled 9 charts

Adenocarcinoma of the Prostate

NCT03327662 2021-01-06

CTC-STOP

Phase 3 Terminated

Adenocarcinoma of the Prostate

NCT02761889 2019-07-23

Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer

Phase NA Unknown

Adenocarcinoma of the Prostate

NCT01832259 2018-12-12

A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection

Phase 2 Completed

30 enrolled 10 charts

Adenocarcinoma of the Prostate

NCT01795365 2018-09-28

Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer

Phase NA Terminated

Adenocarcinoma of the Prostate

NCT00243321 2017-07-13

High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer

Phase NA Completed

Adenocarcinoma of the Prostate

NCT01368003 2015-09-01

STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling

Phase 2 Withdrawn

Adenocarcinoma of the Prostate

NCT00608920 2013-05-24

SPECT

Phase NA Completed

Adenocarcinoma of the Prostate